CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$78.94−5.84 (-6.89%)
Close on Nov 17, 2026Market cap $7.00BP/E –Yield –
CG Oncology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
CG Oncology's total debt was $3.00M at Sep 30, 2026. For fiscal 2025 it was $3.00M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.00M | 0.0% |
| Q2 FY2026 | Jun 30, 2026 | $3.00M | – |
| Q1 FY2026 | Mar 31, 2026 | $3.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $3.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $3.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
See a number that looks wrong?